A novel role for a glycolytic pathway kinase in regulating autophagy has implications in cancer therapy

Aileen R Ariosa1, Daniel J Klionsky1

  • 1a Life Sciences Institute, University of Michigan , Ann Arbor , MI , USA.

Autophagy
|May 25, 2017
PubMed

Insights

Autophagy plays a dual role in cancer, potentially suppressing tumors or promoting their growth. A new study reveals how the glycolytic enzyme PGK1 regulates autophagy in cancer cells under stress.

Area of Science:

  • Cell Biology
  • Oncology
  • Biochemistry

Background:

  • Macroautophagy/autophagy exhibits context-dependent roles in cancer, acting as both a tumor suppressor and a promoter of cancer progression.
  • Understanding the regulatory mechanisms of autophagy is critical for developing targeted anticancer therapies.

Purpose of the Study:

  • To identify key regulatory pathways governing autophagy induction in tumorigenic cells under conditions of hypoxia and glutamine deprivation.
  • To elucidate the role of posttranslational modifications in modulating autophagic flux in cancer.

Main Methods:

  • Investigated the interplay between the glycolytic pathway and autophagy regulation.
  • Utilized biochemical assays to analyze protein phosphorylation and its impact on autophagosome formation.
  • Examined the role of phosphatidylinositol 3-kinase (PtdIns3K) complex activity in response to cellular stress.

Main Results:

  • Discovered that the glycolytic enzyme PGK1 phosphorylates BECN1, a key scaffolding protein in autophagy.
  • Demonstrated that this phosphorylation enhances the activity of the class III PtdIns3K complex, leading to increased PtdIns3P production.
  • Showed that this cascade is crucial for hypoxia- and glutamine deprivation-induced autophagy in cancer cells.

Conclusions:

  • PGK1-mediated phosphorylation of BECN1 represents a critical regulatory step in controlling autophagy under specific stress conditions relevant to the tumor microenvironment.
  • This finding offers a potential therapeutic target for modulating autophagy in cancer treatment.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
6.0K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
10.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.9K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.5K